MDxHealth Q4 Revenues Down 43 Percent, Continues Preparation for Prostate Cancer Test Launch | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDx Health today reported that revenues in the third quarter declined 43 percent year over year.

For the period ended September 30, total revenues were €378,000 ($511,000), down from €669,000 a year ago, with commercial revenues of €267,000 down 41 percent from €451,000 a year ago.

Net loss for the quarter increased 27 percent to €1.9 million from a net loss of €1.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.